Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript
Ted Jenkins: Thank you, operator, and thank you all for participating in todays conference call.
Source: insidermonkey.com
📰 Patrick Vink News
Patrick Vink News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Vink. Real-time updates on events, politics, business and more.
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Spero Therapeutics Second Quarter 2023 Financial Results Conference Call.
Source: insidermonkey.com
Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update
SPA Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr Phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Sath Shukla Became President and...
Source: marketscreener.com
Santhera Publishes Agenda for its Annual General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement...
Source: globenewswire.com
Santhera Pharmaceuticals Holding AG: Santhera Publishes Agenda for its Annual General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland
Source: finanznachrichten.de
Essential Pharma Announces the Appointment of Emma Johnson as Chief Executive Officer
Essential Pharma Announces the Appointment of Emma Johnson as Chief Executive Officer Zug, Switzerland & Egham, UK - 24 May 2023 - Essential Pharma, an international specialty pharma company focused
Source: finanznachrichten.de
Investegate |NMD Pharma Announcements | NMD Pharma: Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors
Investegate announcements from NMD Pharma, Mike Heffernan appointed Chairman of NMD Pharma’s Board of Directors
Source: investegate.co.uk
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors
Mike Heffernan appointed Chairman of NMD Pharma's Board of Directors Brings 30 years of experience building private and public development-stage and commercial biopharmaceutical companies and has overseen
Kostenloser Wertpapierhandel Patrick Vink Eli Lilly Lundbeckfonden Biocapital Mike Heffernan Thomas Holm Pedersen
Source: finanznachrichten.de
Santhera Pharmaceuticals Holding AG: Santhera's Shareholders Approve all Board Proposals at Today's Annual General Meeting
Pratteln, Switzerland, June 30, 2022 - Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all proposals by the Board of Directors at the Annual General Meeting (AGM) held
Source: finanznachrichten.de
SQZ Biotechnologies Reports Full Year 2021 Financial Results and Recent Portfolio Updates
16.03.2022 - SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today reported full year 2021 financial results and recent portfolio updates. “We have much to be proud of as 2021 was a year ...
Patrick Vink Bernard Coulie John Maraganore Exchange Commission Federation Of Clinical Immunology Societies Society For Immunotherapy Of Cancer
Source: wallstreet-online.de